These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31225669)

  • 1. Sensitivity to change of the EORTC quality of life module measuring cancer-related fatigue (EORTC QlQ-Fa12): Results from the international psychometric validation.
    Weis J; Wirtz MA; Tomaszewski KA; Hammerlid E; Arraras JI; Conroy T; Lanceley A; Schmidt H; Singer S; Pinto M; Alm El-Din M; Compter I; Holzner B; Hofmeister D; Chie WC; Harle A; Flechtner HH; Bottomley A;
    Psychooncology; 2019 Aug; 28(8):1753-1761. PubMed ID: 31225669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12).
    Weis J; Tomaszewski KA; Hammerlid E; Ignacio Arraras J; Conroy T; Lanceley A; Schmidt H; Wirtz M; Singer S; Pinto M; Alm El-Din M; Compter I; Holzner B; Hofmeister D; Chie WC; Czeladzki M; Harle A; Jones L; Ritter S; Flechtner HH; Bottomley A;
    J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28376231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric Properties of the Fatigue Questionnaire EORTC QLQ-FA12 in a Sample of Female Cancer Patients.
    Kecke S; Ernst J; Einenkel J; Singer S; Hinz A
    J Pain Symptom Manage; 2017 Dec; 54(6):922-928. PubMed ID: 28807705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13).
    Weis J; Arraras JI; Conroy T; Efficace F; Fleissner C; Görög A; Hammerlid E; Holzner B; Jones L; Lanceley A; Singer S; Wirtz M; Flechtner H; Bottomley A
    Psychooncology; 2013 May; 22(5):1002-7. PubMed ID: 22565359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatigue in the general population: German normative values of the EORTC QLQ-FA12.
    Hinz A; Weis J; Brähler E; Mehnert A
    Qual Life Res; 2018 Oct; 27(10):2681-2689. PubMed ID: 29909484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric properties of the fatigue questionnaire EORTC QLQ-FA12 and proposal of a cut-off value for young adults with cancer.
    Friedrich M; Nowe E; Hofmeister D; Kuhnt S; Leuteritz K; Sender A; Stöbel-Richter Y; Geue K
    Health Qual Life Outcomes; 2018 Jun; 16(1):125. PubMed ID: 29903021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China.
    Zhang L; Wang N; Zhang J; Liu J; Luo Z; Sun W; Woo SM; Chen C; Zhang K; Miller AR; Guo H; Zhang X; Wang C
    Palliat Med; 2016 Apr; 30(4):401-8. PubMed ID: 26121985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
    Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
    BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International validation of the EORTC CAT Core: a new adaptive instrument for measuring core quality of life domains in cancer.
    Petersen MA; Aaronson NK; Conroy T; Costantini A; Giesinger JM; Hammerlid E; Holzner B; Johnson CD; Kieffer JM; van Leeuwen M; Nolte S; Ramage JK; Tomaszewski KA; Waldmann A; Young T; Zotti P; Groenvold M;
    Qual Life Res; 2020 May; 29(5):1405-1417. PubMed ID: 31955374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15.
    Hjermstad MJ; Bergenmar M; Bjordal K; Fisher SE; Hofmeister D; Montel S; Nicolatou-Galitis O; Pinto M; Raber-Durlacher J; Singer S; Tomaszewska IM; Tomaszewski KA; Verdonck-de Leeuw I; Yarom N; Winstanley JB; Herlofson BB;
    Support Care Cancer; 2016 Sep; 24(9):3915-24. PubMed ID: 27113466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.
    Chan A; Lew C; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
    Health Qual Life Outcomes; 2018 Jan; 16(1):20. PubMed ID: 29351803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability and validity of the Turkish version of the EORTC QLQ-C15-PAL for patients with advanced cancer.
    Ozcelik H; Guzel Y; Sonmez E; Aksoy F; Uslu R
    Palliat Support Care; 2016 Dec; 14(6):628-634. PubMed ID: 27068607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Content validation of the EORTC QLQ-C15-PAL with advanced cancer patients and health care professionals from palliative care services in Chile.
    Rojas-Concha L; Hansen MB; Petersen MA; Groenvold M
    BMC Palliat Care; 2020 Jun; 19(1):81. PubMed ID: 32517678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatigue in breast cancer patients: psychometric evaluation of the fatigue questionnaire EORTC QLQ-FA13.
    Fuhrmann K; Mehnert A; Geue K; Hinz A
    Breast Cancer; 2015 Nov; 22(6):608-14. PubMed ID: 24633470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of Life in a Hospice: A Validation of the Croatian Version of the EORTC QLQ-C15-PAL.
    Golčić M; Dobrila-Dintinjana R; Golčić G; Pavlović-Ružić I; Stevanović A; Gović-Golčić L
    Am J Hosp Palliat Care; 2018 Aug; 35(8):1085-1090. PubMed ID: 29466864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
    Blazeby JM; Conroy T; Bottomley A; Vickery C; Arraras J; Sezer O; Moore J; Koller M; Turhal NS; Stuart R; Van Cutsem E; D'haese S; Coens C;
    Eur J Cancer; 2004 Oct; 40(15):2260-8. PubMed ID: 15454251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer.
    Blazeby JM; Conroy T; Hammerlid E; Fayers P; Sezer O; Koller M; Arraras J; Bottomley A; Vickery CW; Etienne PL; Alderson D;
    Eur J Cancer; 2003 Jul; 39(10):1384-94. PubMed ID: 12826041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study to validate the Polish language version of the European Organisation for Research and Treatment of Cancer (EORTC) Colorectal Liver Metastases (QLQ-LMC21) module.
    Paradowska D; Bereza K; Sanna B; Kucharska E; Tomaszewska IM; Dudkiewicz Z; Skotnicki P; Bottomley A; Tomaszewski KA
    Eur J Oncol Nurs; 2017 Aug; 29():148-154. PubMed ID: 28578847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do cancer patients with high levels of distress benefit more than less distressed patients from outpatient art therapy?
    Geue K; Rieckhof S; Buttstaedt M; Singer S
    Eur J Oncol Nurs; 2017 Oct; 30():1-7. PubMed ID: 29031305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.